These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 25544304

  • 1. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
    Xu DP, Cao RY, Xue L, Sun NN, Tong S, Wang XK.
    J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
    [Abstract] [Full Text] [Related]

  • 2. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y, Xu DP, Tong S, Xi SL, Liu ZM, Wang XK.
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
    Puttgen KB, Summerer B, Schneider J, Cohen BA, Boss EF, Bauman NM.
    Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Failure of intralesional propranolol in infantile hemangiomas.
    Torres-Pradilla M, Baselga E.
    Pediatr Dermatol; 2014 Sep; 31(2):156-8. PubMed ID: 24000875
    [Abstract] [Full Text] [Related]

  • 12. Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment.
    Petrovic J, Trifunovic B, Vukomanovic G, Topalovic M, Trajkovic G, Parezanović V.
    J Dermatolog Treat; 2017 Sep; 28(6):554-558. PubMed ID: 28043186
    [Abstract] [Full Text] [Related]

  • 13. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.
    Ji Y, Chen S, Xiang B, Yang Y, Qiu L.
    Sci Rep; 2017 May 04; 7(1):1503. PubMed ID: 28473717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR, Podmelle F, Sadykov RA, Kasimova KR, Metellmann HR.
    Int J Oral Maxillofac Surg; 2013 Jul 04; 42(7):863-7. PubMed ID: 23618833
    [Abstract] [Full Text] [Related]

  • 20. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G, Lv R, Zhao Z, Huo R.
    J Am Acad Dermatol; 2012 Dec 04; 67(6):1210-3. PubMed ID: 22516113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.